Bayer AG R&D Spending Growth & History (BAYN)
Bayer AG's r&d spending was €5.77B for fiscal 2025.
View full Bayer AG company overviewBayer AG annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €5.77B | −€440.0M | −7.09% |
| 2024 | 2024-12-31 | €6.21B | €838.0M | +15.60% |
| 2023 | 2023-12-31 | €5.37B | −€1.20B | −18.27% |
| 2022 | 2022-12-31 | €6.57B | €1.16B | +21.43% |
| 2021 | 2021-12-31 | €5.41B | — | — |
Bayer AG quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €1.52B | €110.0M | +7.81% |
| Q1 2026 | 2026-03-31 | €1.42B | — | — |
| Q4 2025 | 2025-12-31 | €1.41B | — | — |
| Q3 2025 | 2025-09-30 | €1.50B | — | — |
| Q2 2025 | 2025-06-30 | €1.41B | — | — |
Bayer AG r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Bayer AG's r&d spending increased from €5.41B to €5.77B, a change of €357.0M. The latest reported quarter, Q2 2026, shows €1.52B.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
reported R&D expense
TickerStat standardizes research and development expense reported in company official filings, including the software-specific standardized R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗